Active Biotech AB (publ) (STO:ACTI)
0.0395
+0.0008 (2.07%)
Feb 11, 2026, 11:18 AM CET
Active Biotech AB Market Cap
Active Biotech AB has a market cap or net worth of 102.02 million as of February 11, 2026. Its market cap has decreased by -14.36% in one year.
Market Cap
102.02M
Enterprise Value
93.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since March 11, 1998, Active Biotech AB's market cap has decreased from 693.06M to 102.02M, a decrease of -85.28%. That is a compound annual growth rate of -6.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 102.02M | -15.87% |
| Dec 30, 2025 | 121.26M | 4.60% |
| Dec 30, 2024 | 115.93M | -29.80% |
| Dec 29, 2023 | 165.13M | -35.20% |
| Dec 30, 2022 | 254.82M | -7.51% |
| Dec 30, 2021 | 275.52M | 0.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 165.29M |
| IRLAB Therapeutics AB | 138.62M |
| Biovica International AB | 129.61M |
| Simris Group AB (PUBL) | 126.32M |
| Biosergen AB | 106.61M |
| Alligator Bioscience AB | 105.89M |
| Annexin Pharmaceuticals AB | 103.77M |
| Spago Nanomedical AB | 85.67M |